Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy 2024 | Vaccinations and infection prophylaxis in multiple myeloma

Heinz Ludwig • 23 Apr 2024
COMy 2024
Multiple Myeloma

Heinz Ludwig, MD, Wilhelminen Cancer Research Institute, Vienna, Austria, emphasizes the critical role of vaccinations in preventing infections in patients with multiple myeloma (MM). He particularly highlights the importance of vaccines for influenza, pneumococcal disease, and COVID-19. This interview took place at The 10th World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Heinz Ludwig

2:59
KTd versus KRd followed by maintenance or observation in elderly patients with multiple myeloma
Heinz Ludwig • 23 May 2024
2:06
Improving the accuracy of infection reporting in myeloma clinical trials
Heinz Ludwig • 23 May 2024
2:50
Immunotherapy highlights at IMS 2023: bispecific antibodies, CAR-T cells & unanswered questions
Heinz Ludwig • 27 Sep 2023
2:02
Issues with CAR-T slot allocation in myeloma & the promise of locally manufactured products
Heinz Ludwig • 27 Sep 2023

Related Videos

1:37
Integrating BCMA-targeted immunotherapies into challenging multiple myeloma cases
Rakesh Popat • 15 Jun 2024
2:31
Sonrotoclax plus dexamethasone in patients with R/R myeloma harboring t(11;14): a Phase Ib/II trial
Binod Dhakal • 15 Jun 2024
2:17
Emerging therapies to address the unmet need for triple-class refractory multiple myeloma
Maria Victoria Mateos • 1 Jun 2024
0:40
The impact of an evolving first-line setting on subsequent treatment lines in multiple myeloma
Meletios Dimopoulos • 13 Jun 2024
The content of VJHemOnc is intended for healthcare professionals